Palantir

Phase A — Understand the business

Company Overview

Palantir builds and deploys software platforms that act as "the central operating system" for its customers' data. Incorporated in Delaware May 6, 2003; fiscal year ends Dec 31; HQ Denver, CO; co-founders Alex Karp (CEO) and Peter Thiel (Chairman).

What it actually sells (three revenue mechanics, per the 10-QForm 10-QThe quarterly version of the annual report. Lighter, and not audited. "Components of Results of Operations"):

• Palantir Cloud — hosted SaaS subscriptions with stand-ready operations-and-maintenance (O&M); recognized ratably over the term.
• On-Premises Software — term licenses run on the customer's own infrastructure, bundled with O&M as a single performance obligation; recognized ratably.
• Professional services — on-demand user support, UI configuration, training, and "ontology and data modeling" support; recognized over the term.

The product line in market terms: Gotham (government/defense intelligence), Foundry (commercial data-ops backbone), Apollo (deployment/CD layer), and AIP — the Artificial Intelligence Platform (launched 2023), which lets enterprises run LLMs/agents on their own governed data via "ontology." AIP boot camps have become the dominant land-and-expand motion for commercial.

Customers — 954 at YE2025, up from 711 at YE2024 (+34%). Two demand engines: U.S. government (defense, intelligence, civilian agencies — each sub-agency counted separately) and commercial (U.S. commercial is the breakout). Suppliers are essentially third-party cloud hosting (AWS/Azure resold inside Cloud/pilots) plus its own forward-deployed engineering labor — there is no meaningful hardware bill of materials. Competitors: in-house data teams, the hyperscalers' own data/AI stacks (Microsoft Fabric, AWS, Google), Databricks/Snowflake on the data-platform axis, and defense-software entrants (Anduril on the autonomy side, traditional primes on integration).

Contract structure / key payment terms — multi-year, often with customer options. The dollar-weighted average remaining contract duration is ~4 years. Government deals carry termination-for-convenience and option-exercise uncertainty (a real risk the company flags). Deferred revenue $516.9M current + $41.1M noncurrent, and customer deposits $370.1M at Q1-2026 — i.e. customers prepay, a working-capital positive. Concentration is government-heavy but diversifying toward commercial (see Lens 4).

Supply Chain

Palantir is an asset-light software company, so the "supply chain" is a value chain of inputs → platform → end users, not a physical BOM. Named stakeholders along the chain:

• Upstream inputs:
• Compute / hosting — third-party cloud (AWS, Microsoft Azure) resold inside Palantir Cloud and consumed for pilots; this is the single largest direct cost-of-revenue input besides O&M labor.
• Talent — forward-deployed engineers (FDEs) and product/infra staff are the core "raw material"; the labor is in cost of revenue, S&M (pilots), and R&D. SBC is the non-cash form of this input.
• Foundation models — for AIP, Palantir is model-agnostic, orchestrating third-party LLMs (OpenAI, Anthropic, Meta Llama, etc.) on top of its ontology rather than training frontier models itself. This is a strategic choice: it rides the model-price deflation curve instead of paying for it.
• The platform (Palantir): Gotham / Foundry / Apollo / AIP — the integration + governance + deployment layer.
• Downstream / end customers (named):
• U.S. government — Army (the consolidated $10B / 10-year software ceiling; Maven Smart System, $795M modification), Navy (ShipOS), intelligence community, and numerous civilian agencies (each counted separately).
• Allied governments — UK (NHS Federated Data Platform ~£330M; defense), and other NATO-aligned states.
• Commercial enterprises — across energy, healthcare, manufacturing, financial services, and increasingly mid-market via AIP boot camps.

Chokepoints / single-source dependencies: (1) U.S. federal budget & procurement — the demand chokepoint; a continuing-resolution freeze or defense-budget shift hits the government engine directly. (2) Hyperscaler hosting — Palantir depends on the same clouds that also sell competing data/AI stacks (a supplier that is also a competitor). (3) The FDE talent pool — the deployment model is people-intensive; scaling commercial faster than it can hire/retain elite engineers is a genuine constraint, partly mitigated by AIP's productization. Lens fails generic — these names are the chain.

Competitive Advantages (moats)

Where the moat is real:

• Switching costs / embeddedness — once Foundry/AIP becomes the "ontology" and operating layer for an organization's data, ripping it out means re-plumbing the enterprise. The ~4-year weighted contract duration and the expansion dynamics (see NDR below) are evidence the lock-in holds.
• Government accreditation / trust as a moat — clearances, FedRAMP/IL-level authorizations, and a 20-year track record on classified work are a regulatory-and-relationship moat that new entrants cannot speed-run. Palantir famously sued the Army and won (2016), then won the work — a signal of how entrenched the procurement position is.
• The deployment/ontology IP + data-gravity — the proprietary semantic layer that maps messy enterprise/operational data into a governed model is hard to replicate; AIP rides on top of it, which is why Palantir can be model-agnostic and still differentiated.
• Expansion economics — net dollar retention 139% (Q4 2025), and in Q1-2026 most of the revenue increase came from existing customers ($367M of the government increase and $352M of the commercial increase were from pre-existing accounts). That is a land-and-expand flywheel.

Bargaining power: Strong over commercial customers once embedded (they need Palantir more than vice-versa). More balanced with the U.S. government — Palantir needs the budget, but the government increasingly needs Palantir's integration layer for AI-enabled operations, which is shifting power toward Palantir (reflected in sole-source-style awards and the $10B ceiling). Over suppliers (hyperscalers, model labs), Palantir has moderate power because it is model/cloud-agnostic and can substitute.

Where the moat is thinner than bulls claim: AIP's orchestration layer is more contestable than the ontology layer — hyperscalers and Databricks/Snowflake are racing to own enterprise agentic-AI, and the foundation-model labs are pushing "agents-on-your-data" directly. The durable moat is the governed-ontology + government-trust core; the fast-growth commercial AIP layer sits on more contested ground.

Segments

The research layer's our figures is header-only, so segment numbers are read from the filings' MD&A. Palantir reports along two axes: customer type (government vs. commercial) and geography (U.S. vs. international).

Q1-2026 (three months ended 2026-03-31) — by customer type:

So in Q1-2026, U.S. revenue grew ~104% YoY, with U.S. commercial (+133%) the standout — Palantir is no longer a "government stock," it is becoming a U.S.-enterprise AI stock, which is exactly what the multiple is paying for.

Full-year trajectory:

The trend is accelerating revenue (28.8% → 56.2%) with rapidly expanding GAAP margins (operating 5% → 11% → 32%) — the rare combination of growth acceleration and operating leverage. Cause: the AIP commercial engine plus government scale, with cost of revenue falling to ~18% of revenue and OpEx growing far slower than revenue (classic software operating leverage as bookings convert).

---

Phase B — Measure performance

Earnings Result (latest print: Q1-2026, reported 2026-05-04)

The numbers:

• Revenue $1,632.6M, +84.7% YoY (from $883.9M). Beat the ~$1.54B consensus.
• GAAP gross profit $1,416.8M → 86.8% gross margin (88% ex-SBC). Cost of revenue only $215.8M.
• GAAP income from operations $754.0M → 46.2% operating margin (vs 19.9% PY). Adjusted operating margin 60% (vs 44% PY), adjusted income from operations $983.5M.
• GAAP net income $876.4M; net income to common $870.5M.
• GAAP diluted EPS $0.34 (basic $0.36); adjusted EPS $0.33 vs $0.28 consensus.
• Interest income $66.4M + other income $68.2M — the $8B cash pile is now a real earnings contributor.
• Contribution margin 73% (from 61%).

Which lines drove it: U.S. commercial (+133%) and U.S. government ($687M); expansion within existing accounts did most of the work.

Guidance / outlook: management raised FY2026 revenue guidance to $7.65–7.66B (+71% YoY) — a 10-point raise vs prior — well above the ~$7.27B LSEG consensus. U.S. commercial revenue guidance raised to +120% YoY. Q2-2026 guided to ~$1.80B (vs ~$1.68B consensus). FY2026 adjusted FCFFree cash flowCash left after paying to run and maintain the business. Unlike profit, it is hard to flatter with accounting choices. guided to $4.2–4.4B. The tone got more confident, not less.

Balance-sheet flags:

• Cash & equivalents $2,291.6M + marketable securities $5,734.8M = $8.03B liquidity; zero debt.
• Operating cash flow $899M for the quarter (from $310M PY) — cash generation is real, not accrual-flattered.
• Receivables jumped to $1,405.6M from $1,042.1M (Dec 2025) — receivables growing faster than even this revenue rate; watch DSO (see Lens 10), though customer deposits ($370M) and deferred revenue ($517M) offset on the liability side.
• Accumulated deficit narrowed to $(2,691.9)M from $(3,562.4)M as profits compound.

Market reaction: despite the beat-and-raise, the stock fell ~7% on May 5, on valuation/durability concerns. That is the single most important tape signal in this dossier: good news is no longer good enough at this multiple. Post-earnings PTs ranged ~$180–210.

Unusual vs. its own history: 85% growth is the fastest since the 2020 direct listing — an acceleration at $4.5B+ scale is genuinely abnormal for enterprise software and is the crux of the bull case.

Earnings Calls (sentiment trend)

No transcripts in the research layer (transcripts/ empty), so this is ``.

Management's narrative arc across the last several calls:

• Consistent escalation of conviction. Karp's framing moved from "AIP demand is unprecedented" (2024) to explicit triumphalism about a U.S.-enterprise "ferocious" adoption and the company's role in a Western AI buildout (2025–2026). The tone is the most bullish it has been.
• Recurring phrases: "ontology," "AIP," "boot camps," "ferocious"/"unprecedented" demand, "rule of 40 / rule of 80," "the West," "agentic." The rhetoric is unusually ideological for an earnings call — a Karp signature.
• What they lean into now vs. before: much heavier emphasis on U.S. commercial acceleration and on Palantir as critical AI infrastructure for the U.S. government, and on free-cash-flow + GAAP-profitability milestones (a deliberate answer to the "it's all SBC" critique).
• Sentiment shift: monotonically more confident, with management explicitly leaning into the valuation debate (arguing the market underappreciates the durability) rather than hedging. The risk in that posture: it raises the bar — the "stock fell on a beat-and-raise" reaction (Lens 5) shows the market is now pricing the triumphalism, so tone alone no longer moves it up.

Comps

Peers: high-growth enterprise/data/AI-software names. Multiples are `` with source/date; never fabricated. (Index-peer pull n/a — Palantir's index topic is robotics, whose census is hardware names, not software peers; peers below are selected on business comparability.)

Read: Palantir trades at roughly 2.5–3.5x the EV/Sales of the fastest-growing software peers (SNOW 16x, DDOG 21x, CRWD 20x) and at ~30x the software-industry median EV/Sales. The bull defense is that none of those peers is simultaneously growing 71% (guided FY26) and posting 60% adjusted operating margins — Palantir's "Rule of 40" score is off the chart (≈71 growth + ≈60 margin ≈ 130). But even granting a deserved premium, ~55x sales is a multiple that has historically only been sustained by companies that went on to grow into it flawlessly; most did not. Dividend yield: 0% (no dividend) for all growth names.

Stock-Price Catalysts (>5% moves, last ~5 years)

Mostly ``. Pattern of what actually moves PLTR:

• 2023 → 2024 melt-up: from ~$6 (early 2023) up ~2,300% to record highs by late 2024 — driven by the AIP launch (2023) and the commercial inflection.
• S&P 500 inclusion (Sept 2024): forced index buying; a structural re-rating and liquidity event — "speculative → structural".
• Government mega-awards: the consolidated $10B / 10-year Army ceiling and the Maven Smart System $795M modification (2025); Navy ShipOS ($446M); UK defense (~£750M) — defense headlines repeatedly spike the stock.
• Peak ~$207 (Nov 3, 2025), then a ~38% drawdown to ~$127 (June 2026) — driven by valuation de-rating, "AI bubble" fears, a publicized Michael Burry bearish bet, and heavy insider selling, not by any deterioration in the business.
• Earnings reactions have flipped sign: the same magnitude of beat that sent the stock up in 2024 now sends it down (the −7% on the Q1-2026 beat-and-raise).

What the pattern reveals: the market reacts to (1) U.S. commercial acceleration (the multiple's justification), (2) defense/government award headlines, and (3) — now dominantly — valuation/positioning and macro AI-sentiment. At this multiple, PLTR trades as much on flows and narrative (index, retail, "AI trade" risk-on/off) as on fundamentals. That cuts both ways and raises realized volatility.

---

Phase C — Judge people & books

Management

• Track record: Co-founders Alex Karp (CEO) and Peter Thiel (Chairman) built Palantir from a 2003 counter-terrorism tool into a $4.5B-revenue, GAAP-profitable, S&P 500 company — a 20-year compounding story and one of the few "DARPA-adjacent → commercial" successes. Shyam Sankar (CTO / President) is the long-tenured operating engine behind the FDE model and the AIP productization. This is a founder-led team with a demonstrated ability to win in the hardest procurement environment on earth (and to sue the U.S. Army and win).
• Tenure & skin in the game: Founders since 2003. Class F super-voting structure (1,005 Class F shares) gives the founders entrenched control disproportionate to economics — governance is founder-controlled, full stop. Insider ownership is meaningful but the direction of travel is selling (below).
• Capital allocation: Reinvest-and-hoard. $8B net cash, zero debt, growing FCF ($4.2–4.4B guided FY26). Buybacks are token ($75M FY2025) and are dwarfed by SBC ($684M FY2025) — so net share count rises. No dividend. The capital-allocation story is "let cash compound on the balance sheet and fund growth with equity," which is defensible at this growth rate but means shareholders bear ongoing dilutionDilutionIssuing new shares, so each existing share owns a smaller slice of the same company.. ROE/ROIC is structurally high and rising as GAAP net income compounds on an asset-light base (precise ROE not sourced — do not fabricate).
• Red flags: Relentless insider selling. Over the trailing 6 months, insiders executed ~227 open-market sales and 0 purchases. Karp sold ~$132M (incl. a $65.9M block Feb 20, 2026) under a 10b5-1Rule 10b5-1 planA schedule an insider sets in advance saying when their shares will be sold, so the sales cannot be timed on private news. A sale made OUTSIDE such a plan is a live decision, which is why it carries more information. plan authorizing ~10M shares through Sept 12; Sankar ~$50M (incl. $22.5M May 20, much tax-withholding-driven); Thiel filed to offload large blocks. CEO cash comp is modest ($8.6M 2025) — the wealth is equity, and they are monetizing it. 10b5-1Rule 10b5-1 planA schedule an insider sets in advance saying when their shares will be sold, so the sales cannot be timed on private news. A sale made OUTSIDE such a plan is a live decision, which is why it carries more information. plans soften the signal, but the unanimity and scale of selling, with zero insider buying through a 38% drawdown, is a real "insiders think it's fully valued" tell.
• Founder vs. professional manager: Emphatically founder-led / mission-driven — Karp's ideological framing ("the West," defending Western AI supremacy) is a feature for government trust and a recruiting magnet, but it also injects political/reputational risk (Lens 10) and key-person dependency. For this stage (hyper-growth, government-entangled), founder control is mostly an asset.

Forensic Red Flags

Forensic lens — every figure labeled.

• Stock-based compensation flattering non-GAAP. Q1-2026 SBC $201.6M (~12.4% of revenue); FY2025 SBC ~$684M on $4.5B revenue (15%). GAAP is now genuinely profitable (Q1 GAAP op margin 46%), so the historic "all the profit is non-GAAP" critique has weakened — but the gap between adjusted operating margin (60%) and GAAP (46%) is still SBC + payroll taxes ($201.6M + $28.0M add-backs). Dilution is the real cost: net share count rises because buybacks ($75M) << SBC.
• Receivables outrunning revenue. Accounts receivable rose to $1,405.6M from $1,042.1M (Dec→Mar), a ~35% jump in one quarter. Revenue grew 85% YoY but the sequential AR build is worth monitoring for DSO creep / large government billings timing. Offsetting: operating cash flow was strong ($899M) and customer deposits ($370M) + deferred revenue ($517M) show customers prepaying — so this looks like billing-cycle/government timing, not a revenue-quality red flag, but it is the line to watch next quarter.
• Revenue recognition: ratable over multi-year terms with O&M bundled as single performance obligations — conservative, low manipulation surface. RPO $4.1B at YE2025, ~38% to be recognized in the next 12 months. Total Remaining Deal Value $11.2B, +105% YoY — note TRDV assumes all options exercised and no terminations, so it is a softer, more promotional metric than RPORemaining performance obligationsRevenue a company has already signed contracts for but has not yet delivered or booked.; the bookable backlog is the $4.1B RPO.
• Segment reporting: clean two-axis disclosure (customer type × geography); no goodwill/intangible bloat (asset-light; PP&E only $55.7M) — low impairment risk.
• Other-income reliance: $68.2M "other income" + $66.4M interest income contributed ~$135M of pre-tax income in Q1 — a chunk of the bottom line is balance-sheet/below-the-line, not operations. Tax rate is very low (provision $12.2M on $888.6M pre-tax ≈ 1.4%) due to NOLs/valuation-allowance dynamics — a normalizing tax rate is a forward EPS headwind not in trailing numbers.

Regulatory findings (required):

• SEC: No SEC Litigation Releases and no AAERs name Palantir (EDGAR EFTS, LR + AAER, search window 2021-06-20 → 2026-06-20).
• Securities litigation (10-K Item 3 / Note 8): A putative securities class action — Cupat v. Palantir Technologies Inc., et al. (D. Colo., consolidated 1:22-cv-02834), alleging false/misleading statements under the Exchange Act §§10(b)/20(a) and Securities Act §§11/15 — was dismissed with prejudice on April 4, 2025, judgment entered for defendants; plaintiffs filed a Notice of Appeal (May 2, 2025). Net: a favorable resolution, now on appeal. Otherwise "subject to legal proceedings and claims arising in the ordinary course."
• Non-SEC / political & reputational (web): This is the live regulatory/ESG risk for Palantir, and it is material — not to the income statement (yet), but to its social license and certain government relationships:
• ICE / immigration: immigrant-rights litigation over Palantir's "ELITE" (Enhanced Leads Identification & Targeting for Enforcement) ICE tool; ACLU campaign documenting Palantir's role in deportation operations; a ~$30M ICE case-management contract (April 2025) after Palantir had declined ERO work in 2020.
• UK NHS: the cross-party House of Commons Science, Innovation and Technology Committee called for termination of NHS England's Palantir Federated Data Platform contract (June 3, 2026); the BMA advised doctors to limit engagement (Feb 2026); an earlier "covert smear campaign" against a critic was investigated by NHS England. A ~£330M contract and a ~£400M six-year relationship are at reputational risk.
• Defense: Maven Smart System reportedly used to identify strike targets — an ESG/headline risk that is, paradoxically, also the growth driver.
• No FTC/DOJ/CFPB monetary enforcement action found.
• Summary: No SEC accounting enforcement; the one securities class action was dismissed with prejudice (on appeal); the genuine, ongoing exposure is political/reputational/social-license (ICE, NHS), which could cost specific contracts and weigh on the multiple but has not impaired the financials. Verified via SEC EDGAR EFTS (LR, AAER), 10-K Item 3/Note 8, and web search as of 2026-06-20.

---

Phase D — Project & stress-test

Forward Projection (FY2026 / FY2027 / FY2028 EPS)

Built bottom-up from the latest actuals + management guidance; output ``, inputs labeled. (No our model create — watchlist/unattended rule.)

Anchors:

• FY2026 revenue guided $7.65–7.66B (+71%); adjusted FCF $4.2–4.4B guided.
• Q1-2026 adjusted operating margin 60%; adjusted EPS run-rate ~$0.33/qtr and rising.
• Diluted share count ~2.57B and creeping up ~1–2%/yr from SBC.

Base case (most-likely):

• FY2026 revenue ~$7.66B (top of guide; Palantir has serially beaten + raised) → adjusted operating income at ~58–60% margin ≈ $4.45B; after low-but-normalizing tax and below-the-line interest income, FY2026 adjusted EPS ≈ $1.45–1.55. Note: Street adjusted-EPS consensus precision n/a — not cleanly sourced; the quarterly $0.33 actual is the firm anchor.
• FY2027 revenue +~45% to ~$11.1B (decel from 71% as the law of large numbers bites, still elite) at ~60% adj op margin → FY2027 adjusted EPS ≈ $2.05–2.25.
• FY2028 revenue +~35% to ~$15.0B → FY2028 adjusted EPS ≈ $2.75–3.05.

Bull case: U.S. commercial keeps compounding 100%+, government AI budgets expand under the current administration, AIP becomes the default enterprise agentic layer → revenue ~$8.0B / $12.5B / $18B and margins push toward 62–64% → FY2028 adjusted EPS ~$3.50+. Even here, at ~$127 the stock trades ~36x FY2028 bull EPS — rich, not absurd, if growth holds.

Bear case: commercial growth halves to ~40% as competition and AI-budget digestion bite, government lumpiness/CR risk shows up, tax rate normalizes toward 20%+, SBC keeps diluting → revenue ~$7.4B / $9.8B / $12.5B, GAAP-tax-adjusted EPS materially below base → FY2028 adjusted EPS ~$2.10. At that path, ~$127 is ~60x FY2028 bear EPS — the de-rating risk is large.

The honest summary: the business base case is excellent; the stock outcome hinges almost entirely on multiple compression, because even ~30% three-year EPS CAGR leaves the shares expensive on any normalized multiple. (Brier forecast intentionally not logged per unattended rule; if logged, the scoreable line would be PLTR FY2026 adjusted EPS >= $1.50, p≈0.55, resolves 2026-12-31.)

Bull vs Bear

Bull case. Palantir is the rare asset compounding revenue faster at scale (28.8% → 56.2% → 71% guided) while posting 60% adjusted / 46% GAAP operating margins and a Rule-of-40 score near 130 — a combination essentially unmatched in software. The moat (governed ontology, switching costs, 139% NDR, government accreditation) is real and widening into U.S. commercial. AIP positions Palantir as the integration and orchestration layer for enterprise agentic AI — the "operating system" for AI deployment — and it captures that value model-agnostically, riding model-price deflation instead of paying for it. $8B net cash, zero debt, $4.2–4.4B FCF, and a founder team that wins the hardest deals on earth. If the U.S.-and-allied "Western AI buildout" thesis is right, Palantir is a structural, multi-year compounder and today's 38%-off-the-high price is an entry, not a warning.

Bear case (permanent-impairment risks). (1) Valuation is the risk — at ~55x EV/Sales / ~92x forward P/E, the stock discounts a decade of flawless execution; even a great business can be a bad stock from here, and the −7% reaction to a beat-and-raise proves the market is exhausted on good news. (2) Growth durability — U.S. commercial +133% laps into brutal comps; a deceleration to "merely" 40% would crater the multiple even as the business thrives. (3) Competitive encroachment on the AIP layer — hyperscalers, Databricks/Snowflake, and the model labs themselves are racing to own enterprise agentic AI; the contested layer is exactly the high-growth one. (4) Social-license / political risk (ICE, NHS-FDP termination push) could cost contracts and compress the multiple. (5) Government concentration / budget cyclicality and a normalizing tax rate are forward EPS headwinds.

Pre-mortem (18 months out, thesis broke): It's late 2027. U.S. commercial growth decelerated from 100%+ to ~35% as enterprises paused AI spend and hyperscaler-native agentic tools won the mid-market; a government CR/budget fight pushed two big awards right; the tax rate normalized; SBC kept diluting; and the multiple compressed from ~55x to ~20x EV/Sales — a >50% drawdown despite revenue still growing 35%. The business was fine; the price was the problem. (This is the single most plausible way to lose money in PLTR.)

Are multiples too high? Yes on any historical/relative basis (~30x the software median, ~3x the fastest peers). The bull rebuttal — unique growth+margin — is legitimate and supports a premium, but not obviously this premium. The honest read: the multiple already pays for the bull case, so the risk/reward is asymmetric to the downside even if you believe the story.

Contrarian view (what the market refuses to see): Two opposing under-appreciations. Bulls underprice multiple-compression risk — that you can be completely right on the business and still lose money. Bears underprice the GAAP-profitability + FCF inflection — Palantir quietly became a real-earnings, $4B+ FCF machine, which means it can grow into the multiple faster than the "it's all SBC/hype" crowd models. The market is fighting the last war (2021 "unprofitable SaaS") on a company that has changed character.

Devil's Advocate (short-seller)

Dismantling the bull case.

• What structurally breaks the model: Palantir's growth is increasingly a U.S.-commercial AIP story layered on a contested technology (agentic-AI orchestration). If the hyperscalers and model labs make "deploy agents on your governed data" a native, cheap feature, Palantir's fastest-growing layer commoditizes — leaving the slower, lumpier government core. The bull multiple assumes the commercial S-curve is durable and defensible; it may be neither.
• Revenue concentration & what shifts it: Government is still the anchor (U.S. gov $687M in Q1). It is exposed to U.S. budget politics, continuing resolutions, and — newly — administration/political risk cutting both ways (currently a tailwind; a future administration hostile to Palantir's defense/ICE entanglement is a tail risk). Commercial concentration in a handful of large expanding accounts (most growth from existing customers) means a few logo losses or expansion stalls hit hard.
• Why the moat is weaker than bulls think: the durable moat is the ontology + government trust; the orchestration layer riding LLMs is the contested, fast-growth part. Bulls conflate the two.
• Most dangerous competitor bulls underestimate: the hyperscalers' own agentic-AI + data stacks (Microsoft especially) bundling "good-enough" governance into platforms enterprises already own — plus Databricks (private, aggressive) on the data-ops axis and Anduril on defense autonomy.
• Worst capital-allocation / governance issues: token buybacks dwarfed by SBC = perpetual dilution; Class F founder super-voting control removes shareholder leverage; and the unanimous, large-scale insider selling with zero buying through a 38% drawdown is the insiders' own valuation verdict.
• What must hold for today's price: ~50%+ growth for years, margins holding ~60% adjusted, no tax-rate normalization shock, the commercial moat proving durable against hyperscalers, and the multiple not compressing. That is a lot of simultaneous "yes."
• If growth disappoints 20–30%: a path to ~40% growth (from 71% guided) likely triggers multiple compression from ~55x toward 20–25x EV/Sales — a 40–60% drawdown even with revenue still rising. The valuation is the short, not the business.
• Single permanently-impairing scenario & plausibility: hyperscaler/model-lab commoditization of the agentic layer coinciding with a U.S. government budget retrenchment — plausible-but-not-base-case (~15–20%); more likely is a painful de-rating (not impairment) as growth normalizes.

Management Questions (ordered by information value)

1. U.S. commercial grew 133% in Q1 — what is the sustainable growth rate once the boot-camp cohort laps, and how much of current commercial revenue is land (pilots) vs. durably expanded production deployments?
2. As hyperscalers and foundation-model labs ship native "agents-on-your-data," what specifically keeps AIP's orchestration layer from commoditizing — and can you quantify win/loss vs. Microsoft/Databricks in competitive commercial deals?
3. Total Remaining Deal Value is $11.2B but RPO is $4.1B — walk us through the gap (options vs. obligations) and what share of TRDV you'd underwrite as high-probability.
4. With buybacks ($75M) a fraction of SBC ($684M), what is the multi-year net dilution trajectory, and at what point does capital return shift from token to material?
5. The effective tax rate is ~1–2% on NOLs — when does it normalize, to what, and what is the GAAP-EPS impact you're guiding the Street to model?
6. How exposed is the FY2026 government guide to continuing-resolution / budget timing, and how lumpy could the quarterly cadence get on the $10B Army ceiling?
7. The NHS Federated Data Platform faces a parliamentary termination push and the ICE work draws active litigation — how do you quantify the revenue at risk from social-license/political pushback, and is it changing your commercial pipeline anywhere?
8. Net dollar retention is 139% — what is the ceiling, and which cohorts are decelerating first?
9. Accounts receivable rose ~35% sequentially while you guide accelerating growth — what is DSO doing, and how much is government billing-cycle timing vs. structural?
10. How dependent is the AIP roadmap on third-party frontier models, and what is your contingency if model-lab pricing or access terms change adversely?
11. The FDE/deployment model is talent-intensive — what is the productivity curve (revenue per engineer) as AIP productizes, and is hiring a binding constraint on the commercial ramp?
12. What does "winning the Western AI buildout" mean in dollars — TAM, your realistic share, and the 3-year revenue bridge to it?
13. International is underpenetrated vs. the U.S. surge — what is the strategy and the realistic timeline, given the trust frictions in markets like the UK?
14. Given Class F super-voting control, how should public shareholders think about governance accountability and succession/key-person risk around the founder team?
15. At ~55x sales, what specific milestones over the next 8 quarters would you point to as evidence the business is growing into the valuation rather than the valuation needing to come to it?

---